Related references
Note: Only part of the references are listed.Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment
Sara Heeboll et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Dichloroacetate and Trichloroacetate Toxicity in AML12 Cells: Role of Oxidative Stress
Ezdihar Hassoun et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2015)
Resveratrol Inhibits NLRP3 Inflammasome Activation by Preserving Mitochondrial Integrity and Augmenting Autophagy
Ya-Ping Chang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway
Yong Zhang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats
Qing-Rong Pan et al.
NUTRITION RESEARCH (2015)
Effect of resveratrol on experimental non-alcoholic steatohepatitis
Sara Heeboll et al.
PHARMACOLOGICAL RESEARCH (2015)
Autophagy induced by resveratrol suppresses α-MSH-induced melanogenesis
Eun Sung Kim et al.
EXPERIMENTAL DERMATOLOGY (2014)
Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats
Chao Wu Xiao et al.
GENES AND NUTRITION (2014)
Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
Joao Marcus Oliveira Andrade et al.
NUTRITION (2014)
Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice
Wei Zhu et al.
NUTRITION & METABOLISM (2014)
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
Forouzan Faghihzadeh et al.
NUTRITION RESEARCH (2014)
Nutraceuticals and dyslipidaemia: Beyond the common therapeutics
Pietro Scicchitano et al.
JOURNAL OF FUNCTIONAL FOODS (2014)
Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats
Peng Xin et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance
Mohamed Asrih et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats
Marco Di Pascoli et al.
JOURNAL OF HEPATOLOGY (2013)
Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data
A. N. Mavrogiannaki et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Resveratrol Attenuates Obesity-Associated Peripheral and Central Inflammation and Improves Memory Deficit in Mice Fed a High-Fat Diet
Byeong Tak Jeon et al.
DIABETES (2012)
Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2012)
Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1
Honghui Guo et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice
Qiong Chen et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor
Asaf A. Qureshi et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation
Hwan-Hee Jang et al.
NUTRITION & METABOLISM (2012)
Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet
Morten Moller Poulsen et al.
NUTRITION RESEARCH (2012)
Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18
Clarisa Salado et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Selective degradation of p62 by autophagy
Yoshinobu Ichimura et al.
SEMINARS IN IMMUNOPATHOLOGY (2010)
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Giovanni Tarantino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Autophagy regulates lipid metabolism
Rajat Singh et al.
NATURE (2009)
Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo
Bo Shen et al.
HEPATOLOGY (2008)
Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
Jeffrey D. Browning
HEPATOLOGY (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
P Signorelli et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
